Biogen releases long-term Aduhelm data
Biogen Reverses Take on Aducanumab Trial Data | MedPage Today
Congressional Investigation into Alzheimer's Drug Aduhelm Faults the F.D.A. and Biogen - The New York Times
FDA Approval of a New Alzheimer's Drug Comes With Controversy | Smart News| Smithsonian Magazine
The Future of Alzheimer's Treatment? Approval of Aduhelm & Other Anti-Amyloid Antibodies – Montgomery County Medical Society
Controversial FDA Approval Of Alzheimer's Drug Aducanumab Sets Stage For Possible Medicare Coverage Battle
Biogen Plans Regulatory Filing for Aducanumab in Alzheimer's Disease Based on New Analysis of Larger Dataset from Phase 3 Studies | Biogen
/cloudfront-us-east-2.images.arcpublishing.com/reuters/YOZVWDX35VKEVCOQV4LDNO3ZTQ.jpg "U.S. approval of Biogen Alzheimer's drug sends shares soaring, hailed as 'big day\" for patients | Reuters")
U.S. approval of Biogen Alzheimer's drug sends shares soaring, hailed as 'big day" for patients | Reuters
The antibody aducanumab reduces Aβ plaques in Alzheimer's disease | Nature
Biogen's Alzheimer's Drug Gets FDA Approval, Mixed Reviews | The Scientist Magazine®
Aducanumab: will Biogen's Aduhelm recover from its rocky start? - Pharmaceutical Technology
U.S. approval of Biogen Alzheimer's drug sends shares soaring, hailed as 'big day" for patients | Reuters
Aduhelm safety: the data gap on aducanumab's brain swelling side effect
After disastrous start to launch, Biogen still expects 'minimal' sales from Aduhelm this year | Fierce Pharma
Biogen CEO on FDA approval for its Alzheimer's drug - YouTube
With Spotlight on Alzheimer's Disease and Biogen, Competitors' Stocks Soar | BioSpace
Medicare Finalizes Limits on Aducanumab Coverage | MedPage Today
James Deardorff on X: ""Biogen Plans Regulatory Filing for Aducanumab in Alzheimer's Disease" - Hmm... 1. https://t.co/k7Ga4ja0br 2. https://t.co/5cr8gYW72s https://t.co/7NboyUVjWr" / X
Press Releases – Page 2 – Global Alzheimer's Platform Foundation
FDA approves much-debated Alzheimer's drug panned by experts | AP News
Biogen's Aducanumab: A Look at the Drug's History and Recent Updates | BioSpace
Aduhelm (aducanumab) Q+A - Penn Memory Center
June 7, 2021: A Historic Day | The Long and Winding Road...
FDA approves much-debated Alzheimer's drug panned by experts | AP News
